Ainos (AIMD) Metrics: History & Chart

Ainos, Inc.(AIMD)

Biotechnology · Houston, TX

$1.35+0.02 (+1.50%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

About Ainos, Inc.

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.

Houston, TX

41 employees

www.ainos.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Chun-Hsien Tsai

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	0.00%
30D Total Return	-16.87%
YTD Total Return	-18.90%
1Y Total Return	-62.32%
3Y Total Return	-91.29%
5Y Total Return	-98.77%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-18.90%
2025	-28.07%
2024	-77.76%
2023	-33.87%
2022	-95.08%
2021	N/A
2020

CAGR TTM	-62.15%
CAGR 3Y	-55.67%
CAGR 5Y	-58.50%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

AIMD Valuation Metrics

AIMD Stock Price Metrics

AIMD Dividend Metrics

AIMD Growth Rate Metrics

AIMD Discounted Cash Flow Metrics

AIMD Returns By Period

AIMD Yearly Returns

AIMD Average Annual Returns By Period (CAGR)

AIMD Revenue Metrics

AIMD PE Ratio Metrics

AIMD PS Ratio Metrics

AIMD PB Ratio Metrics

AIMD Price to Free Cash Flow Ratio Metrics

AIMD Debt to Equity Ratio Metrics

AIMD PEG Ratio Metrics

AIMD FCF Yield

AIMD Earnings Yield

AIMD EBITDA Yield

AIMD OCF Yield

AIMD EV/EBIT Ratio Metrics

AIMD EV/EBITDA Ratio Metrics

AIMD EV/Assets Ratio Metrics

AIMD EV/Sales Ratio Metrics

AIMD Current Ratio Metrics

AIMD Quick Ratio Metrics

AIMD ROIC Metrics

AIMD Return on Assets Metrics

AIMD Return on Equity Metrics

AIMD Net Profit Margin Metrics

AIMD Gross Profit Margin Metrics

AIMD Tax Rate Metrics

PS Ratio	719.49
PS Ratio Avg TTM	337.84
PS Ratio Avg 3Y	350.15
Current VS TTM Avg	+112.97%
Current VS 3Y Avg	+105.48%
Current VS 5Y Avg	+120.70%

PB Ratio	2.98
PB Ratio Avg TTM	1.75
PB Ratio Avg 3Y	1.41
Current VS TTM Avg	+70.34%
Current VS 3Y Avg	+111.18%
Current VS 5Y Avg	+61.55%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	4.21
Debt/Equity Ratio Avg TTM	2.03
Debt/Equity Ratio Avg 3Y	0.67
Current VS TTM Avg	+107.33%
Current VS 3Y Avg	+530.20%
Current VS 5Y Avg	+618.69%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.13
Ev/Assets Ratio Avg TTM	1.03
Ev/Assets Ratio Avg 3Y	1.01
Current VS TTM Avg	+9.42%
Current VS 3Y Avg	+11.43%
Current VS 5Y Avg	-24.82%

Ev/Sales Ratio	1630.52
Ev/Sales Ratio Avg TTM	683.01
Ev/Sales Ratio Avg 3Y	535.46
Current VS TTM Avg	+138.72%
Current VS 3Y Avg	+204.51%
Current VS 5Y Avg	+183.69%

Current Ratio	0.13
Current Ratio Avg TTM	1.52
Current Ratio Avg 3Y	1.47
Current VS TTM Avg	-91.13%
Current VS 3Y Avg	-90.84%
Current VS 5Y Avg	-89.78%

Quick Ratio	0.12
Quick Ratio Avg TTM	1.34
Quick Ratio Avg 3Y	1.49
Current VS TTM Avg	-91.36%
Current VS 3Y Avg	-92.23%
Current VS 5Y Avg	-90.17%

ROIC	(80.51%)
ROIC Avg 3Y	(53.97%)
ROIC Avg 5Y	(42.86%)
Current VS 3Y Avg	-49.18%
Current VS 5Y Avg	-87.82%
Current VS 10Y Avg	-35.62%

ROA	(73.89%)
ROA Avg TTM	(17.21%)
ROA Avg 3Y	(13.91%)
Current VS TTM Avg	-329.39%
Current VS 3Y Avg	-431.06%
Current VS 5Y Avg	-556.10%

ROE	(440.15%)
ROE Avg TTM	(233.36%)
ROE Avg 3Y	(108.73%)
Current VS TTM Avg	-88.62%
Current VS 3Y Avg	-304.80%
Current VS 5Y Avg	-486.32%

Net Profit Margin	(106283.32%)
Net Profit Margin Avg TTM	(962750.16%)
Net Profit Margin Avg 3Y	(30209.68%)
Current VS TTM Avg	+88.96%
Current VS 3Y Avg	-251.82%
Current VS 5Y Avg	-1356.30%

Gross Profit Margin	(3767.20%)
Gross Pft Margin Avg TTM	(320364.19%)
Gross Pft Margin Avg 3Y	(8529.75%)
Current VS TTM Avg	+98.82%
Current VS 3Y Avg	+55.83%
Current VS 5Y Avg	-3459.21%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.07%
Tax Rate Avg 5Y	0.07%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%